Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin

Molecular Immunology

Volumn 47, Issue 7-8, 2010, Pages 1516-1521

  Valck, Carolina ^a   Ramírez, Galia ^a   López, Nandy ^a   Ribeiro, Carolina H ^a   Maldonado, Ismael ^a   Sánchez, Gittith ^a   Ferreira, Viviana P ^b   Schwaeble, Wilhelm ^c   Ferreira, Arturo ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Complement C1; Serine proteases C1r and C1s; Trypanosoma cruzi calreticulin

Indexed keywords

CALRETICULIN; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S;

ARTICLE; COMPLEMENT ACTIVATION; ENDOPLASMIC RETICULUM; GENE TRANSLOCATION; IMMUNOREACTIVITY; IN VITRO STUDY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; TITRIMETRY; TRYPANOSOMA CRUZI;

ANIMALS; CALCIUM; CALRETICULIN; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HUMANS; PROTEIN BINDING; PROTOZOAN PROTEINS; SERINE PROTEASES; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 77950610010     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.01.019     Document Type: Article

References (30)

1. Aguilar L., Ramirez G., Valck C., Molina M.C., Rojas A., Schwaeble W., Ferreira V., Ferreira A. F(ab′)2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement. Biol. Res. 2005, 38:187-195.
2. Aguillon J.C., Ferreira L., Perez C., Colombo A., Molina M.C., Wallace A., Solari A., Carvallo P., Galindo M., Galanti N., Orn A., Billetta R., Ferreira A. Tc45, a dimorphic Trypanosoma cruzi immunogen with variable chromosomal localization, is calreticulin. Am. J. Trop. Med. Hyg. 2000, 63:306-312.
3. Arlaud G.J., Gaboriaud C., Thielens N.M., Rossi V. Structural biology of C1. Biochem. Soc. Trans. 2002, 30:1001-1006.
4. Chagas C. Nova tripanozomiase humana: Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Mem. Inst. Oswaldo Cruz 1909, 1:159-218.
5. Dias J.C., Silveira A.C., Schofield C.J. The impact of Chagas disease control in Latin America: a review. Mem. Inst. Oswaldo Cruz 2002, 97:603-612.
6. Ferreira V., Molina M.C., Schwaeble W., Lemus D., Ferreira A. Does Trypanosoma cruzi calreticulin modulate the complement system and angiogenesis?. Trends Parasitol. 2005, 21:169-174.
7. Ferreira V., Molina M.C., Valck C., Rojas A., Aguilar L., Ramirez G., Schwaeble W., Ferreira A. Role of calreticulin from parasites in its interaction with vertebrate hosts. Mol. Immunol. 2004, 40:1279-1291.
8. Ferreira V., Molina M.C., Valck C., Rojas A., Ferreira A. Parasite calreticulin: possible roles in the parasite/host interface. Inmunología 2002, 21:156-168.
9. Ferreira V., Valck C., Sanchez G., Gingras A., Tzima S., Molina M.C., Sim R., Schwaeble W., Ferreira A. The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi. J. Immunol. 2004, 172:3042-3050.
10. Fraser D.A., Laust A.K., Nelson E.L., Tenner A.J. C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells. J. Immunol. 2009, 183:6175-6185.
11. Gal P., Dobo J., Zavodszky P., Sim R.B. Early complement proteases: C1r, C1s and MASPs. A structural insight into activation and functions. Mol. Immunol. 2009, 46:2745-2752.
12. Gasque P. Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 2004, 41:1089-1098.
13. 2+-binding interaction domain of C1s, insights into the assembly of the C1 complex of complement. J. Biol. Chem. 2003, 278:32157-32164.
14. Hotez P.J., Molyneux D.H., Fenwick A., Ottesen E., Ehrlich Sachs S., Sachs J.D. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med. 2006, 3:e102.
15. Meri S., Pangburn M.K. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:3982-3986.
16. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem. Inst. Oswaldo Cruz 2003, 98:577-591.
17. Norris K.A., Bradt B., Cooper N.R., So M. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor. J. Immunol. 1991, 147:2240-2247.
18. Norris K.A., Schrimpf J.E. Biochemical analysis of the membrane and soluble forms of the complement regulatory protein of Trypanosoma cruzi. Infect. Immun. 1994, 62:236-243.
19. Phillips A.E., Toth J., Dodds A.W., Girija U.V., Furze C.M., Pala E., Sim R.B., Reid K.B., Schwaeble W.J., Schmid R., Keeble A.H., Wallis R. Analogous interactions in initiating complexes of the classical and lectin pathways of complement. J. Immunol. 2009, 182:7708-7717.
20. Rimoldi M.T., Tenner A.J., Bobak D.A., Joiner K.A. Complement component C1q enhances invasion of human mononuclear phagocytes and fibroblasts by Trypanosoma cruzi trypomastigotes. J. Clin. Invest. 1989, 84:1982-1989.
21. Sim R.B., Porter R.R., Reid K.B., Gigli I. The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement. Biochem. J. 1977, 163:219-227.
22. Steino A., Jorgensen C.S., Laursen I., Houen G. Interaction of C1q with the receptor calreticulin requires a conformational change in C1q. Scand. J. Immunol. 2004, 59:485-495.
23. Stuart G.R., Lynch N.J., Day A.J., Schwaeble W.J., Sim R.B. The C1q and collectin binding site within C1q receptor (cell surface calreticulin). Immunopharmacology 1997, 38:73-80.
24. Stuart G.R., Lynch N.J., Lu J., Geick A., Moffatt B.E., Sim R.B., Schwaeble W.J. Localisation of the C1q binding site within C1q receptor/calreticulin. FEBS Lett. 1996, 397:245-249.
25. Teillet F., Gaboriaud C., Lacroix M., Martin L., Arlaud G.J., Thielens N.M. Crystal structure of the CUB1-EGF-CUB2 domain of human MASP-1/3 and identification of its interaction sites with mannan-binding lectin and ficolins. J. Biol. Chem. 2008, 283:25715-25724.
26. Tomlinson S., Raper J. Natural human immunity to Trypanosomes. Parasitol. Today 1998, 14:354-359.
27. Wallis R., Mitchell D.A., Schmid R., Schwaeble W.J., Keeble A.H. Paths reunited: initiation of the classical and lectin pathways of complement activation. Immunobiology 2009.
28. WHO Control of Chagas disease. World Health Organ. Tech. Rep. Ser. 2002, 905:1-109. back cover.
29. Zapf S., Loos M. Effect of EDTA and citrate on the functional activity of the first component of complement, C1, and the C1q subcomponent. Immunobiology 1985, 170:123-132.
30. Zhou A.Q., Herriott M.J., Leu R.W. Kinetics of the biosynthesis of complement subcomponent C1q by murine macrophages: LPS, immune complexes, and zymosan alone and in combination with interferon-gamma. J. Leukoc. Biol. 1991, 50:453-463.